Showing results (1681-1690 of 5,920) with videos related to
Sort By:
Pageof 592
Arthritis Research & Therapy|July 1, 2004
Measurement of global functional performance in patients with rheumatoid arthritis using rheumatology function testsAgustín Escalante, Roy W Haas, Inmaculada del RincónArthritis Research & Therapy|July 1, 2004
CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic diseaseDuojia Cao, Ronald van Vollenhoven, Lars Klareskog, et al.Arthritis Research & Therapy|July 1, 2004
Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitorJohanna Westra, Berber Doornbos-van der Meer, Peter de Boer, et al.Arthritis Research & Therapy|July 2, 2004
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?Sergio Schwartzman, Roy Fleischmann, G James MorganArthritis Research & Therapy|July 2, 2004
Does safety make a difference in selecting the right TNF antagonist?Roy Fleischmann, David YocumArthritis Research & Therapy|January 12, 2005
Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysisInmaculada Rioja, Chris L Clayton, Simon J Graham, et al.Arthritis Research & Therapy|January 12, 2005
p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritisYuji Yamanishi, David L Boyle, Douglas R Green, et al.Arthritis Research & Therapy|January 12, 2005
Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological gradingHelga Lorenz, Wolfram Wenz, Mate Ivancic, et al.Arthritis Research & Therapy|January 12, 2005
Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodiesMichael Mahler, Marvin J Fritzler, Martin BlüthnerArthritis Research & Therapy|January 12, 2005
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndromeJoyce Villanueva, Susan Lee, Edward H Giannini, et al.Pageof 592